Veterinary Medicines

Advantage 40 mg Lösung zum Auftropfen auf die Haut für Hunde

Authorised
  • Imidacloprid
Download as PDF

Product identification

Medicine name:
Advantage 40 mg Lösung zum Auftropfen auf die Haut für Hunde
Advantage Vet. til hund 100 mg/ml kutanopløsning
Active substance:
  • Imidacloprid
Target species:
  • Dog
Route of administration:
  • Cutaneous use

Product details

Active substance and strength:
  • Imidacloprid
    40.00
    milligram(s)
    /
    0.40
    millilitre(s)
Pharmaceutical form:
  • Cutaneous solution
Withdrawal period by route of administration:
  • Cutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP53AX17
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Available in:
  • Denmark
Package description:
  • Pack sizes 0.4 ml solution per pipette, Pack containing 1 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 2 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 3 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 4 unit dose pipettes, Container: White polypropylene pipettes with caps
  • Pack sizes 0.4 ml solution per pipette, Pack containing 6 unit dose pipettes, Container: White polypropylene pipettes with caps

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Informed consent application (Article 13c of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Elanco Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • KVP Pharma+Veterinär Produkte GmbH
Responsible authority:
  • Danish Health And Medicines Authority
Authorisation number:
  • 18911
Date of authorisation status change:
Reference member state:
  • Austria
Procedure number:
  • AT/V/0020/001
Concerned member states:
  • Denmark
  • Germany
  • Ireland
  • Italy
  • Netherlands
  • Norway
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."